Cordis Corporation

Ethicon, Inc. - USA

Karl K Scheidt

James H Silver

Luis A Davila

David J Wilson

Alan Roy Pelton

Christine Trepanier

Jorge Orlando Mendez

Angelo G Scopelianos

Gerard H Llanos

Mark B Roller

Pallassana V Narayanan

John J Spaltro

David Christian Lentz

William D Shaw, Jr

William Douglas Shaw, Jr

David C Lentz

Jorge O Mendez

Alan R Pelton

Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned.

Medical devices, drug coatings and methods for maintaining the drug coatings thereon

A stent or other intraluminal medical device having markers formed from housings integral with the stent and marker inserts having a higher radiopacity than the stent provides for more precise placement and post-procedural visualization in a vessel, by increasing the radiopacity of the stent under X-ray fluoroscopy. The housings are formed integral to the stent and the marker inserts are made from a material close in the galvanic series to the stent material and sized to substantially minimize the effect of galvanic corrosion.

Radiopacity intraluminal medical device

Growing community of inventors

Pembroke Pines, FL, United States of America

Karl K Scheidt